申请人:Sayre Lawrence M.
公开号:US20080199933A1
公开(公告)日:2008-08-21
A therapeutic agent for selectively inhibiting amine oxidases associated diseases and conditions in humans includes at least one compound selected from the group consisting of propargylamines, polypropargylamines, homopropargylamines, 4-substituted-2-butynylamines, 2- and 3-halloallylamines, pyrroline derivatives, cycloalkenyl branched primary amines, propargyl diamines, homopropargyl amines and diamines, allenyl amines and diamines, chloroallyl diamines, lysyne analogues, β-haloamines, RF-substituted amines, RC
1
-substituted amines, and R3Si substituted amines.